Market slacker Celgene does something good for a change, looking to turn the corner on past mishaps
At this point Celgene has been so battered over its poor performance of the past year you have to do a double take to convince …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
